Search

everythinglearnresearchcommunity

for

Search:↓

Biotin supplements increased biotin levels but did not significantly prevent hair loss in rats on valproic acid.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Eyelash loss can temporarily occur from chemotherapy for retinoblastoma.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Alternative therapies like mushrooms and vinegar extracts can improve health and reduce costs for breast cancer patients.

The combination of encorafenib and binimetinib caused few skin issues.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.